Thank you, Madam Chair.
I'll be sharing my time with MP Ho, if there is time.
I will start with Dr. Hamelin.
Doctor, in your testimony and in the answers to my colleagues, you answered that there is no structure to commercialized medicine in Canada. Is it that there's no structure or that there are too many structures and too much red tape that comes into play when it comes to commercializing the drugs? Which one is it? Is it too much red tape, or is it no red tape?
